BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 178234)

  • 41. Future prospects for immunotherapy.
    Rosenberg SA
    Cancer; 1975 Aug; 36(2):821-4. PubMed ID: 168962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical trials of immunotherapy: present status.
    Morton DL; Goodnight JE
    Cancer; 1978 Nov; 42(5):2224-33. PubMed ID: 363256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Current concepts of tumor immunology. III. Immune therapy.
    Krause CJ; Nysather JO
    Ann Otol Rhinol Laryngol; 1978; 87(1 Pt 1):138-41. PubMed ID: 623411
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antitumor reactivity of mononuclear leukocytes from cancer patients receiving immunotherapy with BCG.
    Mavligit GM; Hersh EM
    Med Pediatr Oncol; 1978; 5(1):115-26. PubMed ID: 370532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.
    Morton DL; Eilber FR; Joseph WL; Wood WC; Trahan E; Ketcham AS
    Ann Surg; 1970 Oct; 172(4):740-9. PubMed ID: 5272336
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunotherapy of metastases enhances subsequent chemotherapy.
    Hanna MG; Key ME
    Science; 1982 Jul; 217(4557):367-9. PubMed ID: 6283635
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sequential evaluation of general immune competence in cancer patients: correlation with clinical course.
    Eilber FR; Nizze JA; Morton DL
    Cancer; 1975 Mar; 35(3):660-5. PubMed ID: 234294
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of BCG immunotherapy in malignant disease.
    Hersh EM; Gutterman JU; Mavligit GM; Reed RC
    South Med J; 1975 Jun; 68(6):673-5. PubMed ID: 1169816
    [No Abstract]   [Full Text] [Related]  

  • 49. Chemotherapy for malignant melanoma: a brief review and personal experience.
    Milton GW; McCarthy WH
    Aust N Z J Surg; 1978 Feb; 48(1):53-5. PubMed ID: 96784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. BGG immunotherapy of local subcutaneous growths and post-surgical pulmonary metastases of a transplanted rat epithelioma of spontaneous origin.
    Baldwin RW; Pimm MV
    Int J Cancer; 1973 Sep; 12(2):420-7. PubMed ID: 4792349
    [No Abstract]   [Full Text] [Related]  

  • 51. Immunological approaches to cancer treatment.
    Baldwin RW
    Jpn J Surg; 1980 Mar; 10(1):7-14. PubMed ID: 6966345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Proceedings: Some aspects of the use of B.C.G. in the treatment of advanced malignant disease.
    Grant RM; Mackie RM; Cochran AJ; Hoyle D; Ross C
    Br J Cancer; 1974 Aug; 30(2):182. PubMed ID: 4471590
    [No Abstract]   [Full Text] [Related]  

  • 53. Combination of radiotherapy and immunotherapy in the treatment of Lewis's tumour.
    Serrou B; Dubois JB
    Eur J Cancer (1965); 1977; 13(4-5):489-91. PubMed ID: 872863
    [No Abstract]   [Full Text] [Related]  

  • 54. Immunotherapy of cancer with "immune" RNA. A preliminary report.
    Pilch YH; de Kernion JB; Skinner DG; Ramming KP; Schick PM; Fritze D; Brower P; Kern DH
    Am J Surg; 1976 Nov; 132(5):631-7. PubMed ID: 984310
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lung cancer: An immunologic viewpoint and the prospects for immunotherapy.
    Gross NJ; DeMeester TR
    Surg Clin North Am; 1976 Feb; 56(1):219-31. PubMed ID: 1251303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunotherapy as an adjunct to surgery in the treatment of cancer.
    Eilber FR; Holmes EC; Morton DL
    World J Surg; 1977 Sep; 1(5):547-54. PubMed ID: 602232
    [No Abstract]   [Full Text] [Related]  

  • 57. Editorial: Approaches to local immunotherapy.
    Freireich EJ
    JAMA; 1975 Dec; 234(12):1258. PubMed ID: 1242757
    [No Abstract]   [Full Text] [Related]  

  • 58. [Nonspecific active immunotherapy in surgical treatment of patients with pulmonary cancer].
    Hrinevych IuIa; Hanul VL; Fil'chakov FV; Smolanka II; Bororov LV
    Klin Khir; 2000; (2):48-51. PubMed ID: 10857293
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The logic of adjunctive therapy in surgical patients with resectable cancer.
    Balch CM; Maddox WA
    South Med J; 1978 Aug; 71(8):951-5, 957. PubMed ID: 356271
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer immunotherapy: STINGing systemically.
    Villanueva MT
    Nat Rev Drug Discov; 2018 Dec; 18(1):15. PubMed ID: 30591729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.